Lowell, MA, United States of America

Jennifer E Ring


 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Inventor Spotlight: Jennifer E. Ring**

Introduction

Jennifer E. Ring, an innovative inventor based in Lowell, MA, has made significant contributions to the field of biochemistry and molecular biology. Her work focuses on developing methods and compositions that target specific biological complexes involved in various diseases and disorders. With one patent to her name, she stands out for her dedication to advancing medical science.

Latest Patents

Jennifer holds a patent titled "PRPK-TPRKB modulators and uses thereof." This patent presents innovative methods for identifying agents that can modulate the PRPK, TPRKB, OSGEP, and LAGE3 proteins, along with their homologs. The invention further details the PRPK/TPRKB complex and KEOPS complex, providing vital insights into the development of treatments for conditions associated with these CT antigens. This groundbreaking work may pave the way for new therapeutic approaches to combat a variety of health challenges.

Career Highlights

Currently, Jennifer is employed at Taiho Pharmaceutical Company Limited, where her expertise in protein modulation is utilized for developing effective treatments. Her work at the company embodies her commitment to applying scientific research to real-world medical issues.

Collaborations

In her professional journey, Jennifer has collaborated with esteemed colleagues such as Eun Sun Park and Henry Efrem Pelish. These collaborations reflect her strong team-oriented approach and her ability to work alongside talented professionals in the pharmaceutical industry to achieve common goals in health innovation.

Conclusion

With her innovative spirit and dedication to enhancing medical treatments, Jennifer E. Ring is indeed a noteworthy inventor. Her patent on PRPK-TPRKB modulators underscores her role in pushing the boundaries of what is possible in the realm of biological research. As she continues her work at Taiho Pharmaceutical Company Limited, the future looks promising for further innovations that may significantly impact healthcare and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…